Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Fennec Pharmaceuticals Inc. (FENC)

10.42 -0.41 (-3.79%)
As of 12:27:49 PM EST. Market Open.
Trade FENC on Coinbase
FENC Q3 2026 earnings call
November 12, 2026 at 8:30 AM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
59,221 44,642 47,538 21,252 1,535
Cost of Revenue
-3,715 -3,764 -3,184 -1,259 -86
Gross Profit
55,506 40,878 44,354 19,993 1,449
Selling, General and Administrative Expenses
-56,415 -46,910 -41,479 -32,708 -20,507
Research and Development Expenses
-216 -250 -307 -56 -3,531
Depreciation, Amortization and Depletion
-64 -64 -89 -287 -149
Operating Income/Expenses
-56,669 -47,224 -41,875 -33,051 -24,187
Total Operating Profit/Loss
-1,163 -6,346 2,479 -13,058 -22,738
Total Net Finance Income/Expense
102 -1,293 -2,387 -2,953 -783
Net Investment Income
-20 26 -163 -34 -193
Irregular Income/Expenses
-2,022 -2,022 0 -- --
Non-Operating Income/Expenses, Total
-1,940 -3,289 -2,550 -2,987 -976
Pretax Income
-3,103 -9,635 -71 -16,045 -23,714
Provision for Income Tax
-106 -106 -365 0 --
Net Income from Continuing Operations
-3,251 -9,741 -436 -16,045 -23,714
Net Income after Extraordinary Items and Discontinued Operations
-3,251 -9,741 -436 -16,045 -23,714
Net Income after Non-Controlling/Minority Interests
-3,251 -9,741 -436 -16,045 -23,714
Net Income Available to Common Stockholders
-3,251 -9,741 -436 -16,045 -23,714
Diluted Net Income Available to Common Stockholders
-3,251 -9,741 -436 -16,045 -23,714
Basic EPS
-0.13 -0.34 -0.02 -0.60 -0.90
Diluted EPS
-0.13 -0.34 -0.02 -0.60 -0.90
Basic Weighted Average Shares Outstanding
32,064.50 28,577 27,294 26,574 26,275
Diluted Weighted Average Shares Outstanding
33,471.50 28,577 27,294 26,574 26,275
Income Statement, Supplemental
EBIT
-3,205 -8,342 2,316 -13,092 -22,931
EBITDA
-3,102 -8,239 3,116 -12,805 -22,782
Normalized EBITDA
6,425 790 8,340 -7,417 -18,502
Normalized Income
6,276 -2,066.35 4,004.40 -10,657 -19,434
Total Unusual Items
9,527 9,029 5,224 5,388 4,280
Total Unusual Items Excluding Goodwill
9,527 9,029 5,224 5,388 4,280
12/31/2022 - 9/15/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: